Resultados de la búsqueda 171-180 of 11371 for Raised white cell count

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This may lead to an increased risk of serious infections requiring hospitalization and an increased risk of secondary non-blood-based (hematologic) cancers.

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer. Study ...

3. Hematología - Ensayos clínicos - Mayo Clinic

   Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells.

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer. Study ...

5. Hematología - Ensayos clínicos - Mayo Clinic

   This may lead to an increased risk of serious infections requiring hospitalization and an increased risk of secondary non-blood-based (hematologic) cancers.

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This is a peripheral blood Collection Protocol to study the T-cell ... high (80-90%) frequency of MUC1 ... count ≥ 1,500 /microliter, and platelets ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Also, we will evaluate whether the peripheral blood immune cell ... In addition, obesity, a chronic inflammatory state, is associated with increased colorectal ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This may lead to an increased risk of serious infections requiring hospitalization and an increased risk of secondary non-blood-based (hematologic) cancers.

9. Hematología - Ensayos clínicos - Mayo Clinic

   This is a peripheral blood Collection Protocol to study the T-cell ... high (80-90%) frequency of MUC1 ... count ≥ 1,500 /microliter, and platelets ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This may lead to an increased risk of serious infections requiring hospitalization and an increased risk of secondary non-blood-based (hematologic) cancers.